Yasmine S. Abd-El
Cairo, C 12622, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.
Journal: Virology journal
Published: December 11, 2024
Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt.
Journal: BMC biotechnology
Published: October 11, 2024
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.
Journal: Virology journal
Published: July 19, 2024
Immunogenicity study of a Novel DNA-Based HCV vaccine candidate.
Journal: The Egyptian journal of immunology
Published: July 12, 2024
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice.
Journal: BMC infectious diseases
Published: January 08, 2019
Neutralizing activity and safety of human monoclonal antibodies against hepatitis C virus.
Journal: Human antibodies
Published: October 18, 2017
Level of Human Antibodies Targeting HCV E1/E2 Peptides and Spontaneous Clearance of HCV in Blood Donors.
Journal: Clinical laboratory
Published: February 07, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026